Ivyland, Pennsylvania- July 2, 2025- LifeLens Technologies, Inc. (LifeLens),

announced the initiation of their clinical study designed to evaluate the

performance and usability of its investigational solution to deliver lab-based

diagnostic results in a wearable device for sleep assessment.

LifeLens has developed an innovative physiological monitoring platform designed to

improve clinical decision making, patient outcomes, and operational efficiency. The

prospective study will assess their platform’s ability to collect and analyze

physiological signals related to sleep-related respiratory diseases such as

obstructive sleep apnea, including vital signs such as SpO2, sleep duration, sleep

stages, sleep quality metrics and activity levels, in an adult population.

The study is designed to compare clinical data collected by the LifeLens device(s)

with data collected from in-facility and home sleep assessment methods. The goal

is to evaluate the LifeLens platform’s accuracy, reliability, and usability. Data from

this study will be used to support future development activities and regulatory

submissions.

“Sleep disorders affect millions of people and are often underdiagnosed”, said Dr.

Zeeshan Kahn, DO, (Medical Director, Sleep Center of Bucks County). “By

combining clinically informed design with advanced sensor and communications

technology, this platform can become a foundational tool in sleep health

management that helps to improve the accuracy and efficacy of home sleep

testing. This study will help demonstrate its potential clinical impact”.

“We are on a mission to deliver on the promise of physiological monitoring to

improve outcomes and reduce cost of care in the most challenging chronicdiseases. This study is a pivotal step toward that vision, validating our platform’s

ability to deliver more accurate and actionable assessment of sleep-related

respiratory disease in a home testing environment,” said Landy Toth, founder and

CEO, LifeLens Technologies, Inc.

ABOUT THE COMPANY

LifeLens, a private healthcare company founded in 2016, has developed a

revolutionary system capable of acquiring extensive physiological, environmental

and contextual data to assess real-time health status and performance. With its

comprehensive communications and visualization capabilities, the LifeLens system

is designed to provide actionable information, where and when it is needed,

supporting health professionals in making data-driven decisions that improve the

health and welfare of patients.

The technology that drives the LifeLens comprehensive monitoring platform has

been tested by the U.S. military in over 40 fielding events since 2021. During this

time, it has helped military leaders to monitor clinical-grade vital signs, mitigate heat

and musculoskeletal injuries, and determine unit readiness in real-time training and

operational environments in the most extreme conditions on earth.

For more information, visit www.lifelenstech.com.

FORWARD LOOKING STATEMENTS

This press release contains “forward-looking statements” concerning the development of

LifeLens Technologies, Inc. products, their potential benefits and attributes, and the company’s

expectations regarding its prospects. These statements involve risks and uncertainties that could

cause actual results to differ materially from those expressed or implied. LifeLens Technologies,

Inc. undertakes no obligation to update these statements as circumstances change.